By Josh White
Date: Wednesday 02 Jul 2025
(Sharecast News) - Avacta Therapeutics provided a second-quarter business update on Wednesday, reporting continued progress in its oncology pipeline and strengthening of its leadership team as it advanced its 'preCISION' drug development strategy.
By Josh White
Date: Friday 06 Jun 2025
(Sharecast News) - Avacta Group reported a reduced pre-tax loss of £28.98m from continuing operations in 2024 on Friday, down from £31.13m the year prior, as it accelerated its transformation into a pure-play oncology biotech.
By Benjamin Chiou
Date: Tuesday 27 May 2025
(Sharecast News) - Life sciences company Avacta Therapeutics has announced that it has had to delay the release of its annual results by a week.
Currency | UK Pounds |
Share Price | 61.50p |
Change Today | 6.50p |
% Change | 11.82 % |
52 Week High | 75.00 |
52 Week Low | 27.50 |
Volume | 9,614,478 |
Shares Issued | 404.55m |
Market Cap | £248.80m |
RiskGrade | 461 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 2 |
Buy | 0 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 3 |
No dividends found |
Time | Volume / Share Price |
16:35 | 4,757 @ 61.50p |
16:35 | 1,000 @ 61.50p |
16:35 | 12 @ 61.50p |
16:35 | 10 @ 61.50p |
16:35 | 20 @ 61.50p |
You are here: research